Two interesting articles on rcs today. I can relate to the

New Post Public Reply Private Reply Replies (0) Message Board
trding
417
Two interesting articles on rcs today. I can relate to the comments in bold, having had friends and family call me to announce they just found a cure for cancer. Or A17 posting ever single advancement in other companies that does anything similar to what Cydy is doing.
First
https://www.realclearscience.com/articles/201...11029.html

Last week I read an article about CRISPR, the latest tool scientists are using to edit DNA. It was a great piece – well researched, beautifully written, factually accurate. It covered some of the amazing projects scientist are working on using CRISPR, like bringing animals back from extinction and curing diseases. It also gave me the heebies, but not for the reason you might expect.

My unease was the echo of a feeling I’d had during the early days of my PhD, when some fellow malaria researchers made a discovery that was reported on the news. I was thrilled for them, but I understood the incremental nature of the work they were doing. I knew that in a real-world, drugs-in-the-clinic sense, we were no closer to a breakthrough than we’d been the day before. I thought the reporters had communicated that clearly. Five minutes later my Dad called to ask if I was out of a job, and what I was going to do now that malaria was cured.

I don’t pretend to understand all the myriad reasons for the gaping chasm between what scientists say and what the public hears. Lately though, I’m starting to think it might have something to do with the metaphors we use, and the way they shape our perception of the complexity involved.

Take CRISPR. It’s most often described as a pair of molecular scissors that can be used to modify DNA, the blueprint for life. And when we read that, I think most of us start imagining something like a child with her Lego bricks strewn in front of her, instruction booklet in one hand, scissors in the other. One set of pictograms, one model; one gene, one disease; one snip, one cure. We’re there in a blink. CRISPR seems like it can work miracles.


I want to stress that the molecular scissors metaphor is pretty damn accurate as far as it goes. But in focusing on the relatively simple relationship between CRISPR and DNA, we miss the far more complicated relationship between DNA and the rest of the body. This metaphor ignores an entire ecosystem of moving parts that are crucial for understanding the awe-inspiring, absolutely insane thing scientists are trying to do when they attempt gene editing.

I prefer the metaphor of malware
In my research I use CRISPR from time to time. To design experiments and interpret results effectively, I need a solid way to conceptualise what it can (and can’t) do. I do not think of CRISPR as molecular scissors.

Instead I imagine a city. The greater metropolis represents the body, the suburbs are organs, the buildings are cells, the people are proteins, and the internet is DNA.

In this metaphor CRISPR is malware. More precisely, CRISPR is malware that can search for any chosen 20-character line of code and corrupt it. This is not a perfect metaphor by any stretch, but it gets me closer to understanding than almost anything else.


Alzheimer’s is like a riot
As an example, let’s look at Alzheimer’s, one of the diseases CRISPR is being touted to cure. The headlines are usually some variation of “CRISPR to correct Alzheimer’s gene!”, and the molecular scissors analogy is never far behind.

It seems reasonable to me that someone could read those words and assume that chopping away the disease-gene with the DNA-shears should be relatively simple. When the cure doesn’t appear within five years, I can understand why that same person would come to ask me why Big Pharma is holding out (this has happened to me more than once).

Now let’s see how it looks using the malware metaphor. The consensus is that Alzheimer’s manifests when a specific protein goes rogue, causing damage to cells and thereby stopping things from working properly inside the brain. It might have a genetic cause, but it’s complicated. In our allegorical city, what would that look like?

I think riots would come close. Rampaging humans (proteins) destroying houses and property (cells), thereby seriously derailing the normal functioning of a specific suburb (the brain).

And you want to fix that with malware?

It’s hard to predict the domino effect
Can you imagine for a second trying to stop soccer hooligans smashing things on the streets of Buenos Aires by corrupting roughly three words in the FIFA by-laws with what’s essentially a jazzed-up command-F function?

I’m not saying it’s not possible – it absolutely is.

But think of all the prior knowledge you need, and all the pieces that have to fall in place for that to work. You’d have to know that the riots are caused by football fans. You’d have to understand which rule was bothering them (heaven help you if it’s more than one), and if that rule causes drama at every game. You’d have to find a 20-character phrase that, when corrupted, would change how the rule was read, rather than just making a trivial typo.

You’d have to know that the relevant footballers have access to the updated rule book, and you’d have to know there were no other regulations making your chosen rule redundant. You’d have to know there aren’t any similar 20-character phrases anywhere on the internet that might get corrupted at the same time (like in the rules for presidential succession say, or in the nuclear warhead codes). Even then you’d still be rolling the dice.

Even if you stop the riots successfully, which of us really know the long-term consequences of changing the World Game forever?


Reflecting the right level of complexity
At this point, you might say I’m stretching the metaphor a bit far; that this analogy has become a little stuck up its own behind. You’d not be wrong.

But by thinking the problem this way, we’ve just given ourselves a pretty decent feel for the complications of polygenic disease, incomplete penetrance, missense/nonsense mutations, epigenetic silencing, genetic compensation, off target and germline effects – all without a single word of science jargon.

These are real difficulties scientists are trying to work through to make sure CRISPR is effective and safe. That’s why it takes a long time and costs a lot of money. That’s why most of the promising leads end up going nowhere.

Amazingly, astoundingly, sometimes it works.The Conversation

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Heat: Channel Stuffing Allegations Arise

Updated Category News Views 7

Gildan's Stocks Take a Dive Amid Allegations Just when you thought the market swings were calming down, Gildan Activewear Inc. (NYSE: GIL) lands in hot water, sending investors scrambling. The spotlight's on them, thanks to some eye-catching accusations from Jehoshaphat Research. The word on the street is Gildan's been engaging in some questionable financial gymnastics...

Continue Reading
iReprogram and U-M Join Forces to Combat Diabetes

Updated Category News Views 1

Diabetes: A New Frontier in Disease Management Here we go, folks. Imagine a universe where diabetes isn't just controlled but potentially reversed at the cellular level. That's the bold vision taking shape in Ann Arbor, Michigan. A new partnership between iReprogram and the University of Michigan (U-M) sets the stage for a seismic shift in how we tackle diabetes,...

Continue Reading
From Samhain to Spooktacular: Ireland's Halloween Origins

Updated Category News Views 0

Tracing Halloween's Roots: A Journey to Ireland The chill in the air can only mean one thing—Halloween is creeping up on us. But amid all the plastic pumpkins and supermarket candy, have you ever stopped to wonder where it all began? Well, folks, lace up your boots because Ireland is calling, and it's got more than a pot of gold at the end of this rainbow. No, the real...

Continue Reading
Microencapsulation Market to Hit $24B by 2031

Updated Category News Views 2

Think about wrapping a tiny gift inside a bubble that's not only protective but also dissolves at just the right moment. That, my friends, is microencapsulation summed up—and it's becoming a big deal. With the market poised to jump from $16.90 billion in 2026 to a whopping $24.02 billion by 2031, at a steady clip of 7.3% annually, there's a lot for investors to chew on...

Continue Reading
Fosun Drives Global Growth of China's Drug Innovations

Updated Category News Views 4

A New Phase for Chinese Pharmaceuticals There's a shift in the pharma world, with Fosun International leading the charge. Chinese innovative drugs are stepping onto the global stage, thanks to efforts like those of Chen Qiyu, Co-CEO of Fosun. At the Sustainability Global Leaders Conference 2026, he spoke about transforming Chinese market players into worldwide...

Continue Reading
Tower Crane Rental Market: Growth Predicted by 2031

Updated Category News Views 0

Leaning Upward: The Crane Rental Surge Ever wonder why folks are keeping a tight grip on crane rentals? Well, that's because this heavyweight industry isn't just lifting steel; it's lifting market potential. According to MarketsandMarkets™, the global tower crane rental market is set to balloon from a cool $17.99 billion in 2026 to a whopping $23.19 billion by 2031,...

Continue Reading
Alaska Air Group's Q3: Facing Headwinds and Strategies

Updated Category News Views 6

Weathering the Q3 Storm Alaska Air Group's third quarter results are in the bag, and let me tell ya, it's a mixed bag of sour lemons and hopeful limes. Reporting a net loss of $147 million or ($1.32) per share ain't the kind of results that plaster smiles on investors' faces. But hey, it's a volatile sector if there ever was one, especially with fuel costs ballooning to a...

Continue Reading
AI Traffic Sensing By AglaiaSense and Leopard Imaging

Updated Category News Views 7

Revolutionizing Traffic Sensing with Privacy The buzz in Barcelona this November is all about AglaiaSense and Leopard Imaging teaming up at the Smart City Expo World Congress. They're not just hitting exhibit after exhibit. These two are set to roll out their cutting-edge AI traffic sensing tech, and from what I'm hearing, it's miles ahead of anything we've seen before....

Continue Reading
Life After Debt: Freedom, Confidence, and Wellbeing

Updated Category News Views 12

The Unseen Upside of Financial Freedom Debt can feel like a ball and chain, dragging down everything from your sleep to your relationships. But shred that debt, and suddenly the world looks different. Accredited Debt Relief's recent survey of 1,000 folks who've paid off at least $5,000 in unsecured debt uncovers the remarkable transformations that follow. According to 93%...

Continue Reading
Samsung & NVIDIA Partner to Boost AI Supply Chain

Updated Category News Views 0

Making Moves in Semiconductor Supply Picture this: two giants locking arms to tackle the AI revolution head-on. Samsung Electro-Mechanics and NVIDIA have struck a strategic pact set to shake up the semiconductor supply chain. With a multi-year supply deal kicking off in 2026, this is no garden-variety handshake. Investment in Facilities: Bigger Fish to Fry As part of this...

Continue Reading

Top 5 Most Recently Viewed Articles

DeFi Development Corp. Teams Up with AllDomains for Growth

Updated Category News Views 94

Exciting Partnership Announcement Between DeFi Development Corp. and AllDomains Labs DeFi Development Corp. (NASDAQ: DFDV) has recently made headlines with a significant announcement regarding a new collaboration with AllDomains Labs. This partnership aims to bolster operations within the Solana ecosystem by establishing a top-notch validator while enhancing community...

Continue Reading
Innovative Measurement Solutions Unveiled at ZEISS Event

Updated Category News Views 190

Transforming Manufacturing Challenges into Opportunities ZEISS Industry Tech Days is an exciting event series that gathers manufacturers from various sectors to explore how cutting-edge metrology solutions can revolutionize processes and foster sustainable innovation. Event Overview These Tech Days will take place across several states, bringing together industry leaders...

Continue Reading
Scenthound Joins Forces with VMG for Enhanced Dog Wellness Growth

Updated Category News Views 319

Scenthound Partners with VMG for Enhanced Dog Wellness Growth In a significant move within the pet care industry, Scenthound, a prominent dog wellness franchise, has announced a strategic partnership with VMG Partners, a well-renowned growth equity firm boasting a legacy of aiding iconic consumer brands in their expansion efforts. This collaboration stands as a vital...

Continue Reading
Investing Insights: Morningstar's Stock Journey Over 20 Years

Updated Category News Views 195

Understanding Morningstar's Long-Term Investment Potential Morningstar (NASDAQ: MORN) has consistently shown its resilience and growth in the stock market over the past two decades. With an impressive annual market outperformance of 20.19%, it has cultivated an average annual return of 29.23%. Currently, the company's market capitalization stands at an extraordinary $9.76...

Continue Reading
Exploring the Ten-Year Investment Journey with KB Home

Updated Category News Views 133

Understanding KB Home's Ten-Year Growth Investing can often seem overwhelming, especially when trying to determine the best opportunities. Take KB Home (NYSE: KBH), for instance. Over the last decade, KB Home has managed to outperform the market with an impressive average annual return of 16.81%. This growth is something that any investor would appreciate, showcasing not...

Continue Reading